Literature DB >> 11722807

Epidemiology and Prevention of Invasive Aspergillosis.

David W. Warnock1, Rana A. Hajjeh, Brent A. Lasker.   

Abstract

Aspergillus species are the most common causes of invasive mold infections in immunocompromised persons. This review examines the available information regarding the rising incidence of invasive aspergillosis in different high-risk groups, including persons with acute leukemia, hematopoietic stem cell transplant recipients, and liver and lung transplant recipients. The risk factors for infection in these groups are discussed. Because Aspergillus species are widespread in the environment, it is difficult to link specific sources and exposures to the development of human infections. However, molecular strain typing and other studies indicate that a significant number of Aspergillus infections are now being acquired outside the health care setting, either before patients are admitted to hospital, or after they have been discharged. The role of environmental control measures and antifungal drug prophylaxis in the prevention of hospital- and community-acquired aspergillosis is discussed.

Entities:  

Year:  2001        PMID: 11722807     DOI: 10.1007/s11908-001-0087-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  79 in total

1.  The occurrence of fungi in hospital and community potable waters.

Authors:  M Arvanitidou; K Kanellou; T C Constantinides; V Katsouyannopoulos
Journal:  Lett Appl Microbiol       Date:  1999-08       Impact factor: 2.858

2.  Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-01-03

3.  Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis.

Authors:  H Reichenspurner; P Gamberg; M Nitschke; H Valantine; S Hunt; P E Oyer; B A Reitz
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

4.  Aspergillus infections in bone marrow transplant recipients.

Authors:  J R Wingard; S U Beals; G W Santos; W G Merz; R Saral
Journal:  Bone Marrow Transplant       Date:  1987-08       Impact factor: 5.483

5.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

6.  Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.

Authors:  D Caillot; O Casasnovas; A Bernard; J F Couaillier; C Durand; B Cuisenier; E Solary; F Piard; T Petrella; A Bonnin; G Couillault; M Dumas; H Guy
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

7.  Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit.

Authors:  V G Loo; C Bertrand; C Dixon; D Vityé; B DeSalis; A P McLean; A Brox; H G Robson
Journal:  Infect Control Hosp Epidemiol       Date:  1996-06       Impact factor: 3.254

8.  Primary cutaneous aspergillosis associated with Hickman intravenous catheters.

Authors:  M D Allo; J Miller; T Townsend; C Tan
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

9.  Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation.

Authors:  D R Hospenthal; K J Kwon-Chung; J E Bennett
Journal:  Med Mycol       Date:  1998-06       Impact factor: 4.076

10.  Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.

Authors:  V A Morrison; R J Haake; D J Weisdorf
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965

View more
  3 in total

1.  Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis.

Authors:  Shane R Baistrocchi; Mark J Lee; Melanie Lehoux; Benjamin Ralph; Brendan D Snarr; Robert Robitaille; Donald C Sheppard
Journal:  J Infect Dis       Date:  2017-06-01       Impact factor: 5.226

2.  Assessment of ribosomal large-subunit D1-D2, internal transcribed spacer 1, and internal transcribed spacer 2 regions as targets for molecular identification of medically important Aspergillus species.

Authors:  Hans P Hinrikson; Steven F Hurst; Timothy J Lott; David W Warnock; Christine J Morrison
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Aspergillus ustus infections among transplant recipients.

Authors:  Anil A Panackal; Alexander Imhof; Edward W Hanley; Kieren A Marr
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.